|
|||||
|
|
TBX2 and TBX3: The special value for anticancer drug targets |
|
| Authors: | Juan Lu Xiang-Ping Li Qi Dong Hsiang-fu Kung Ming-Liang He |
| Affiliation: | 1. Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;2. Stanley Ho Center for Emerging Infectious Diseases, School of Public Health, The Chinese University of Hong Kong, Hong Kong, China;3. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China;4. Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China |
| Abstract: | |
| Keywords: | CDKs, cyclin-dependent kinases EGR1, early growth response 1 FGF, fibroblast growth factor MEFs, mouse embryonic fibroblasts RD, repression domain RNAi, RNA interference siRNA, small interfering RNA TGFβ, transforming growth factor β UMS, ulnar-mammary syndrome CTCL, cutaneous T-cell lymphoma |
| 本文献已被 ScienceDirect 等数据库收录！ | |